Epithelial to mesenchymal transition of mesothelial cells in tuberculous pleurisy

Yonsei Medical Journal

Volumn 52, Issue 1, 2011, Pages 51-58

  Kim, Changhwan ^a   Kim, Dong Gyu ^a   Park, Sung Hoon ^a   Hwang, Yong Il ^a   Jang, Seung Hun ^a   Kim, Cheol Hong ^a   Jung, Ki Suck ^a   Min, Kwangseon ^a   Lee, Jae Woong ^a   Jang, Young Sook ^a  

^a Hallym University College of Medicine   (South Korea)

Author keywords

Epithelial to mesenchymal transition; Il 1 ; Mesothelial cells; Pleural fibrosis; Tgf 1; Tuberculous pleurisy

Indexed keywords

CYTOKERATIN; CYTOKINE; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

ARTICLE; CELL ISOLATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MESOTHELIUM CELL; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUS PNEUMOTHORAX; TUBERCULOUS PLEURISY;

CELLS, CULTURED; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; PLEURA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUBERCULOSIS, PLEURAL;

EID: 78650555023     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2011.52.1.51     Document Type: Article

References (36)

1. Seibert AF, Haynes J Jr, Middleton R, Bass JB Jr. Tuberculous pleural effusion. Twenty-year experience. Chest 1991;99:883-6.
2. de Pablo A, Villena V, Echave-Sustaeta J, Encuentra AL. Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis? Chest 1997;112:1293-7.
3. Huggins JT, Sahn SA. Causes and management of pleural fibrosis. Respirology 2004;9:441-7.
4. Mutsaers SE, Prele CM, Brody AR, Idell S. Pathogenesis of pleural fibrosis. Respirology 2004;9:428-40.
5. Bariety J, Hill GS, Mandet C, Irinopoulou T, Jacquot C, Meyrier A, et al. Glomerular epithelial-mesenchymal transdifferentiation in pauci-immune crescentic glomerulonephritis. Nephrol Dial Transplant 2003;18:1777-84.
6. Nicolás FJ, Lehmann K, Warne PH, Hill CS, Downward J. Epithelial to mesenchymal transition in Madin-Darby canine kidney cells is accompanied by down-regulation of Smad3 expression, leading to resistance to transforming growth factor-beta-induced growth arrest. J Biol Chem 2003;278:3251-6.
7. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001;159:1465-75.
8. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002;110:341-50.
9. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Müller GA, et al. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 2002;61:1714-28.
10. Yáñez-Mó M, Lara-Pezzi E, Selgas R, Ramírez-Huesca M, Domínguez-Jiménez C, Jiménez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003;348:403-13.
11. Selgas R, Bajo A, Jiménez-Heffernan JA, Sánchez-Tomero JA, Del Peso G, Aguilera A, et al. Epithelial-to-mesenchymal transition of the mesothelial cell--its role in the response of the peritoneum to dialysis. Nephrol Dial Transplant 2006; 21 Suppl 2: ii2-ii7.
12. Aguilera A, Yáñez-Mó M, Selgas R, Sánchez-Madrid F, López-Cabrera M. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients. Curr Opin Investig Drugs 2005;6:262-8.
13. Maeda J, Ueki N, Ohkawa T, Iwahashi N, Nakano T, Hada T, et al. Local production and localization of transforming growth factor-beta in tuberculous pleurisy. Clin Exp Immunol 1993;92:32-8.
14. Yanagawa H, Yano S, Haku T, Ohmoto Y, Sone S. Interleukin-1 receptor antagonist in pleural effusion due to inflammatory and malignant lung disease. Eur Respir J 1996;9:1211-6.
15. Kroegel C, Antony VB. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 1997;10:2411-8.
16. Kunz CR, Jadus MR, Kukes GD, Kramer F, Nguyen VN, Sasse SA. Intrapleural injection of transforming growth factor-beta antibody inhibits pleural fibrosis in empyema. Chest 2004;126:1636-44.
17. Ceyhan BB, Demiralp E, Karakurt ZL, Karakurt S, Sungur M. Transforming growth factor beta-1 level in pleural effusion. Respirology 2003;8:321-5.
18. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003;15:740-6.
19. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 1995;154:8-20.
20. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003;9:964-8.
21. Khalil N, Parekh TV, O'Connor R, Antman N, Kepron W, Yehaulaeshet T, et al. Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis. Thorax 2001;56:907-15.
22. Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, et al. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2001;163:1476-83.
23. Vesey DA, Cheung CW, Cuttle L, Endre ZA, Gobé G, Johnson DW. Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production. Kidney Int 2002;62:31-40.
24. Fan JM, Huang XR, Ng YY, Nikolic-Paterson DJ, Mu W, Atkins RC, et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis 2001;37:820-31.
25. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390:465-71.
26. Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S, et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci U S A 2001;98: 6686-91.
27. Tepass U, Truong K, Godt D, Ikura M, Peifer M. Cadherins in embryonic and neural morphogenesis. Nat Rev Mol Cell Biol 2000;1:91-100.
28. Arias AM. Epithelial mesenchymal interactions in cancer and development. Cell 2001;105:425-31.
29. Pötter E, Bergwitz C, Brabant G. The cadherin-catenin system: implications for growth and differentiation of endocrine tissues. Endocr Rev 1999;20:207-39.
30. Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithecell lial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2:76-83.
31. Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000;2: 84-9.
32. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol cell 2001;7:1267-78.
33. Kim K, Lu Z, Hay ED. Direct evidence for a role of beta-catenin/ LEF-1 signaling pathway in induction of EMT. Cell Biol Int 2002; 26:463-76.
34. Hay ED, Zuk A. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis 1995;26:678-90.
35. Hurwitz S, Leiman G, Shapiro C. Mesothelial cells in pleural fluid: TB or not TB? S Afr Med J 1980;57:937-9.
36. Follador EC, Pimentel M, Barbas CS, Takagaki TY, Kairalla RA, Deheinzelin D, et al. [Tuberculous pleural effusion: clinical and laboratory evaluation]. Rev Hosp Clin Fac Med Sao Paulo 1991; 46:176-9.